Products for Research Use Only
RegisterLogin

Tuvonralimab

CAT: 0804-HY-P99540-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99540-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tuvonralimab (PSB-205) is a humanized IgG1 monoclonal antibody against CTLA-4. Tuvonralimab can be used in the research of tumors. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control[2].
CAS Number
2417649-44-4
Product Name Alternative
PSB-205; QL1706 (iparomlimab/tuvonralimab) ; PBS105
UNSPSC
12352203
Target
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tuvonralimab.html
Purity
99.14
Solubility
10 mM in DMSO
Smiles
[Tuvonralimab]
Molecular Weight
(145 kDa)
References & Citations
[1]Keam SJ. Iparomlimab and Tuvonralimab: First Approval. Drugs. 2025 May;85 (5) :699-706.|[2]Ian Wilkinson, et al. Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names. MAbs. 2022 Jan-Dec;14 (1) :2123299.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 4

Alternative Products

CatalogName
BA5947-5Tuvonralimab
GTR18337801-01Tuvonralimab Antibody
HB651096-01Research Grade Tuvonralimab
E55B0843Tuvonralimab (Reference antibody)
A138602Tuvonralimab Biosimilar (Monoclonal, IgG1)
ICH5951-50mgTuvonralimab Biosimilar - Research Grade
GTR18697292-01Tuvonralimab Human Monoclonal Antibody
GTR18780839-01(Tuvonralimab) Biosimilar Reference Antibody
A135551Tuvonralimab Biosimilar (Monoclonal, IgG1-kappa)
RA0175-01Tuvonralimab (Biosimilar Reference Antibody) (CTLA4)

Popular Products